Stockscreener 앱 받기
0.7575
1.58%
-0.0147
Lakeshore Biopharma Co Ltd 주식(LSB)의 최신 뉴스
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 - The Manila Times
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 - StockTitan
LakeShore Biopharma names Xu Wang as new CEO - Investing.com India
LakeShore Biopharma names Xu Wang as new CEO By Investing.com - Investing.com Canada
LakeShore Biopharma Announces Leadership Transitions - Kilgore News Herald
LakeShore Biopharma Announces Leadership Transitions - StockTitan
Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) Short Interest Update - Defense World
Short Interest in Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) Rises By 20.1% - Defense World
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition - Longview News-Journal
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 - PR Newswire
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 - Morningstar
LakeShore Biopharma Insider Ups Holding By 3,083% During Year - Simply Wall St
ROSEN, LEADING INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action InvestigationYS, SMIH - Marketscreener.com
LakeShore Biopharma (NASDAQ:LSB) Stock Quotes, Forecast and News Summary - Benzinga
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition - Macau Business
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition - PR Newswire
LakeShore Biopharma Insider Ups Holding By 3,083% During Year - Yahoo Finance UK
LakeShore Biopharma Insider Ups Holding By 3,083% During Year - Yahoo Finance
LakeShore Biopharma Co., Ltd (NASDAQ:LSB) Looks Inexpensive After Falling 36% But Perhaps Not Attractive Enough - Simply Wall St
LakeShore Biopharma Announces Executive ReshuffleTipRanks.com - TipRanks
The Hunt for Virus Treatments Continues Post Covid-19 - Exeter Lakeshore Times-Advance
Exploring High Insider Ownership In US Growth Companies - Simply Wall St
LakeShore Biopharma Co., Ltd (NASDAQ:LSB): Are Analysts Optimistic? - Simply Wall St
LakeShore Biopharma Co., Ltd (NASDAQ:LSB): When Will It Breakeven? - Yahoo Finance
Does Dun & Bradstreet Holdings (NYSE:DNB) Have A Healthy Balance Sheet? - Simply Wall St
YS, SMIH INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages YS Biopharma Co., Ltd. f/k/a ... - Marketscreener.com
YS Biopharma announces name change to 'LakeShore Biopharma'TipRanks.com - TipRanks
YS Biopharma to change legal name to LakeShore Biopharma (NASDAQ:YS) - Seeking Alpha
YS Biopharma Announces Name Change to LakeShore Biopharma USAEnglish - PR Newswire
YS Biopharma Announces Name Change to LakeShore Biopharma - PR Newswire
YS Biopharma Announces Results of Extraordinary General Meeting - Thailand Business News
YS Biopharma Approves Major Corporate ChangesTipRanks.com - TipRanks
YS Biopharma Announces Results of Extraordinary General Meeting APACEnglish - PR Newswire
YS Biopharma Announces Results of Extraordinary General Meeting - PR Newswire
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer - PR Newswire
Arrow Electronics First Quarter 2024 Earnings: Misses Expectations - Simply Wall St
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PR Newswire
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 - PR Newswire
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine - PR Newswire
YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine - PR Newswire
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility - PR Newswire
Sprinklr Full Year 2024 Earnings: EPS Beats Expectations - Simply Wall St
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries - PR Newswire
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024 - PR Newswire
YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. - PR Newswire
YS Biopharma Announces US$40 Million Private Placement Financing - PR Newswire
Sagimet Bio stock surges after trial win for NASH drug - Seeking Alpha
YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting - PR Newswire
ADIA-backed Lake Shore confident about turning around Koregaon Park mall - The Financial Express
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA - PR Newswire
Virtuous Retail in talks to sell malls for about $500 million - IndiaTimes
Diffusion to merge with EIP Pharma in all-stock deal - Seeking Alpha
YS Biopharma (YS) Stock Price, News & Analysis - MarketBeat
YSYS Biopharma Co., Ltd. Latest Stock News & Market Updates - StockTitan
Who's getting sued: December 26, 2022 - Business in Vancouver
ADIA-backed Lake Shore acquires Viviana Mall from Ashwin Sheth, GIC for Rs 1,900 crore - IndiaTimes
Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen ... - BioCentury
Stock Symbol Change History | Track Ticker Changes - Nasdaq
Lake shore India, Reach properties tie up to develop Gurgaon retail project - IndiaTimes
Lake Shore acquires Hyderabad mall for Rs 1,000 crore - Economic Times
UAE-based VPS Healthcare to invest Rs 1,000 crore in India in healthcare facilities - IndiaTimes
CEN Biotech under investigation by stock market regulator - Windsor Star
Public told to contact police with concerns over marijuana firm - The Globe and Mail
Concerns mount over pot company - Windsor Star
A Lakeshore medical marijuana facility may become one of the largest - CTV News Windsor
0.98%
2.02%
자본화:
|
볼륨(24시간):